Table 2.
Clinical and radiological comparison between patients with and without ASPECTS_agreement
AD | AA | p value | |
---|---|---|---|
Age (mean ± SD), years | 72±15 | 65±13 | 0.11 |
Female/male | 9/6 | 31/19 | 0.89 |
Hypertension | 10/15 | 31/50 | 0.74 |
Atrial fibrillation | 6/15 | 13/50 | 0.30 |
Diabetes mellitus | 3/15 | 10/50 | 1.00 |
CHD | 2/15 | 6/50 | 1.00 |
Dyslipidemia | 7/15 | 18/50 | 0.46 |
Statin therapy | 6/15 | 17/50 | 0.71 |
Previous stroke | 1/15 | 11/50 | 0.27 |
Glycemia (mean ± SD), mg/dl | 122±34 | 130±53 | 0.61 |
Systolic blood pressure at onset (mean ± SD), mm Hg | 150±29 | 144±34 | 0.58 |
Diastolic blood pressure at onset (mean ± SD), mm Hg | 81±14 | 78±17 | 0.57 |
Time to CT (mean ± SD), min | 150±141 | 244±137 | 0.02* |
Time to CT <120 min | 10/15 | 7/42 | <0.01* |
Site of vessel occlusion | 0.25 | ||
MCA-M1 | 7/15 | 23/50 | |
MCA-M2 | 2/15 | 11/50 | |
Proximal ICA | 0/15 | 6/50 | |
Terminal ICA | 6/15 | 10/50 | |
Recanalization (TICI score 2b–3) | 12/15 | 39/50 | 1.00 |
Final infarct volume on 24 h CT (mean ± SD), ml | 55±74 | 24±35 | <0.01* |
3-month mRS score <3 | 6/15 | 24/50 | 0.77 |
AD = ASPECTS disagreement; AA = ASPECTS agreement; CHD = coronary artery disease; TOAST = trial of Org 10172 in Acute Stroke Treatment.
p < 0.05 statistical significance for intergroup differences. It was assessed by Pearson's χ2 or Fisher's exact test for categorical variables and by Student t test for continuous variables.